Movement Alert|Corteva, Inc. Falls 10.51% in Regular Trading, Q2 Revenue Misses Expectations Despite EPS Beat

Market Focus08-01

On July 31, Corteva, Inc. declined 10.51% in regular trading, trading at approximately $79.86/share, with turnover of $3.6 billion. The sharp selloff followed the company's Q2 earnings release.

Corteva reported Q2 adjusted earnings of $2.30 per diluted share, beating the FactSet consensus estimate of $2.22-$2.24 and up from $2.20 a year earlier. However, revenue fell to $6.38 billion from $6.46 billion year-over-year, significantly missing the analyst estimate of approximately $6.58-$6.6 billion. While the company raised its full-year operating EPS guidance to a range of $3.60-$3.80, up from a prior forecast of $3.45-$3.70, the revenue shortfall weighed heavily on sentiment. Earlier this year, Corteva had flagged persistent pricing headwinds in its crop protection segment, with low-single-digit price declines expected for the year. Multiple analysts had already downgraded the stock to neutral prior to the earnings release.

Within the Fertilizers & Agricultural Chemicals sector, weakness was broad-based. Among peers, FMC Corp fell 7.35%, Mosaic fell 2.06%, Scotts Miracle-Gro fell 1.48%, Nutrien Ltd. fell 1.4%, and CF Industries fell 0.92%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment